Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Go back to Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Dermira (DERM) Tops Q3 EPS by $1.15

November 7, 2023 4:29 PM EST

Dermira (NASDAQ: DERM) reported Q3 EPS of $0.99, $1.15 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $34.54 million versus the consensus estimate of $16.9 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

... More